Robert Coffin, President & Chief R&D Officer at Replimune Group, Inc. (REPL), sold 120,000 shares at $44.87 ($5.3M) on 2021-01-22, disclosed to the SEC on 2021-01-26.
Open-market sale of $5.3M REPL by President & Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.99 | 29,803 | $1.3M | 24.6% |
| 2 | $43.99 | 29,803 | $1.3M | 24.6% |
| 3 | $44.87 | 30,197 | $1.4M | 25.4% |
| 4 | $44.87 | 30,197 | $1.4M | 25.4% |
| Total | $44.43 avg | 120,000 | $5.3M | 100% |
| Filing → |
| REPL | SELL | 2022-05-18 | $167K | — | Filing → |
| REPL | SELL | 2021-07-07 | $625K | — | Filing → |
| REPL | SELL | 2021-06-30 | $3.0M | — | Filing → |